Page 5 - நடக்கிறது உடன் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Depression Scores Did Not Differ Significantly Between Patients Who Used Psilocybin or Escitalopram at 6 weeks These findings, from a phase 2, double-blind, randomized, controlled trial, were published in the New England Journal of Medicine. Patients (N=59) with long-standing, moderate to severe major depressive disorder were recruited via an advertisement in the United Kingdom in 2019. Patients were randomized to receive 2 doses of 25 mg psilocybin with a daily placebo for 6 weeks (n=30) or 2 doses of 1 mg psilocybin with 3 weeks of daily 10 mg escitalopram and 3 weeks of 20 mg escitalopram (n=29). Patients were assessed by magnetic resonance imaging (MRI) and performed cognitive and affective processing tasks.

United kingdomBritish columbiaUnited statesNorfolk countyRichard feynmanIrwin simonTommy chongMatt stangKareem burkeResearch centreA company witha combined market capToronto stock exchangeAcreage holding capital partnersInvestment banking firm canaccord genuityAcreage holdingsHealth canada